CARDIOVASCULAR RISK ESTIMATION IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH BIOLOGICS OR C-DMARDS

被引：0
|
作者：
Mole, Evangelia [1 ]
Gazi, Sousana [1 ]
Moschou, Dimitra [1 ]
Mpaili, Georgia [1 ]
Theodorakopoulos, Stavros [1 ]
Zoupidou, Konstantina [1 ]
Kontodimopoulos, Nikolaos [2 ]
机构：
[1] KAT Gen Hosp Attica, Dept Rheumatol, Athens, Greece
[2] KAT Gen Hosp Attica, Div Management, Athens, Greece
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2019年 / 78卷
关键词：
D O I：
10.1136/annrheumdis-2019-eular.2504
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0323
引用
收藏
页码：1620 / 1620
页数：1
相关论文
共 50 条
  • [21] Cardiovascular Safety of Biologics and JAK Inhibitors in Patients with Rheumatoid Arthritis
    Kang, Eun Ha
    Liao, Katherine P.
    Kim, Seoyoung C.
    CURRENT RHEUMATOLOGY REPORTS, 2018, 20 (07)
  • [22] Denosumab, Biologics and the Risk of Infection in Patients with Rheumatoid Arthritis
    Haraoui, Boulos
    Choquette, Denis
    Coupal, Louis
    Sauvageau, Diane
    Zo'o, Alexandre Adjo'o
    JOURNAL OF RHEUMATOLOGY, 2015, 42 (07) : 1274 - 1274
  • [23] Cardiovascular Risk in Rheumatoid Arthritis Patients Treated with Methotrexate versus Hydroxychloroquine
    He, Mengdong
    Pawar, Ajinkya
    Desai, Rishi
    Glynn, Robert
    Lee, Hemin
    Weinblatt, Michael
    Solomon, Daniel H.
    Kim, Seoyoung
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [24] Cardiovascular Risk in Rheumatoid Arthritis: Comparing TNF-α Blockade with Nonbiologic DMARDs
    Solomon, Daniel H.
    Curtis, Jeffrey R.
    Saag, Kenneth G.
    Lii, Joyce
    Chen, Lang
    Harrold, Leslie R.
    Herrinton, Lisa J.
    Graham, David J.
    Kowal, Mary K.
    Kuriya, Bindee
    Liu, Liyan
    Griffin, Marie R.
    Lewis, James D.
    Rassen, Jeremy A.
    AMERICAN JOURNAL OF MEDICINE, 2013, 126 (08): : 730.e9 - 730.e17
  • [25] Efficacy of Therapeutic Education for Patients With Rheumatoid Arthritis Treated With Biologics
    Bouden, Selma
    Ben Ayed, Hiba
    Khemir, Haifa
    Rouached, Leila
    Ben Tekaya, Aicha
    Mahmoud, Ines
    Tekaya, Raoudha
    Saidane, Olfa
    Abdelmoula, Leila
    MUSCULOSKELETAL CARE, 2025, 23 (01)
  • [26] SERIOUS INFECTIOUS COMPLICATIONS IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH BIOLOGICS
    Aronova, E.
    Gridneva, G.
    Kudryavtseva, A.
    Lukina, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1131 - 1131
  • [27] Skin autofluorescence as a tool for cardiovascular risk estimation in patients with rheumatoid arthritis
    Bakker-Aling, S. H.
    van Woerkom, J. M.
    Zomer, T. P.
    Buscher, H. C. J. L.
    van Bemmel, T.
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2019, 66 : E7 - E8
  • [28] Prediction of infection risk in rheumatoid arthritis patients treated with biologics: are we any closer to risk stratification?
    Jani, Meghna
    Barton, Anne
    Hyrich, Kimme
    CURRENT OPINION IN RHEUMATOLOGY, 2019, 31 (03) : 285 - 292
  • [29] Gender and Discontinuation of Biologic DMARDs in Patients with Rheumatoid Arthritis: Data from the Mexican Biologics Registry
    Rivera, Vijaya
    Sicsik Ayala, Sandra
    Vega Morales, David
    Irazoque-Palazuelos, Fedra
    Miranda Hernandez, Dafhne
    Casasola Vargas, Julio
    Carrillo Vazquez, Sandra
    Pena Ayala, Angelica
    Castillo Ortiz, Angel
    Munoz Monroy, Omar
    Duran Barragan, Sergio
    Paz Viscarra, Aleni
    Torres Valdez, Estefania
    Xibille Friedmann, Daniel
    Zamora Tehozol, Erick A.
    Valdes Corona, Luis
    Ramos Sanchez, Azucena
    Santana Portillo, Natalia
    Guerrero Diaz, Francisco
    Vazquez Zaragoza, Miguel
    Zepeda Moreno, Claudia
    Alvarado Sanchez, Kitzia
    Rivera Valencia, Melanea
    Pacheco Tena, Cesar
    Alpizar-Rodriguez, Deshire
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [30] CARDIOVASCULAR RISK IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Nikitina, N. M.
    Rebrov, A. P.
    TERAPEVTICHESKII ARKHIV, 2009, 81 (06) : 29 - 34
12345